| Condition Brief | Condition Text | View |
|---|---|---|
| None | Contraception | View |
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | AE adverse event | View |
| None | AIDS acquired immunodeficiency syndrome | View |
| None | ALT (SGPT) alanine aminotransferase | View |
| None | ART antiretroviral therapy | View |
| None | AST (SGOT) aspartate aminotransferase | View |
| None | DCF data collection forms | View |
| None | DMC Data Monitoring Committee | View |
| None | FDA (U.S.) Food and Drug Administration | View |
| None | GCP Good Clinical Practice guidelines | View |
| None | HB sAg Hepatitis B surface antigen | View |
| None | ICH International Conference of Harmonization | View |
| None | IND Investigational New Drug Application | View |
| None | IRB Institutional Review Board | View |
| None | IU International units | View |
| None | mg milligram(s) | View |
| None | mm3 cubic millimeter(s) | View |
| None | PCR polymerase chain reaction | View |
| None | SAE serious adverse event | View |
| None | µg microgram | View |
| None | ULN upper limit of the normal range | View |
| None | WB Western Blot | View |